Dr Reddy’s shares in focus after recall of mislabelled Levetiracetam injection in US
The potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, ...
Medical Dialogues4 天
Dr Reddy's Labs recalls epilepsy drug in US over infusion bag mislabeling
Hyderabad: Dr Reddy’s Laboratories Ltd., is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride ...
Fierce Pharma3 天
Dr. Reddy’s, Sun Pharma and Zydus issue US recalls, citing failed specs and labeling issues
The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...
pharmaphorum4 天
UCB's non-cannabis drug for severe epilepsy gets NHS okay
The drug is the first non-cannabinoid option for ... and would be a successor to its other epilepsy therapies - including Keppra (levetiracetam), a former blockbuster, but which is now facing ...
Yahoo Finance2 天
Bright Minds Biosciences Inc. (DRUG)
After hours: March 19 at 6:52:53 PM EDT Loading Chart for DRUG ...
Medscape1 天
Management of Epilepsy During Pregnancy: Evidence-based Strategies
UK Medical Eligibility Criteria for Contraceptive Use Category 1: A condition for which there is no restriction for the use of the contraceptive method with the condition or in that circumstance.
Dr. Reddy’s, Alvotech announce FDA acceptance of BLA for AVT03
Dr. Reddy’s Laboratories (RDY) and Alvotech (ALVO) announced that the U.S. Food and Drug Administration, FDA, has accepted a 351(k) Biologic ...
Medscape2 天
The Pathophysiological and Pharmacological Basis of Current Drug Treatment of Migraine Headache
Other potential PAM agents without class 1 data include levetiracetam ... Dihydroergotamine mesylate – generic, DHE 45® 1 mg/ml ampules 1 mg im. or sc.; can be repeated at 1 h intervals ...